MARTINEK, Jan, Hana SVECOVA, Zuzana VACKOVA, Radek DOLEZEL, Ondřej NGO, Jana KRAJCIOVA, Eva KIESLICHOVA, Radek JANOUSEK, Alexander PAZDRO, Tomas HARUSTIAK, Lucie ZDRHOVA, Pavla LOUDOVA, Petr STIRAND a Julius SPICAK. Per-oral endoscopic myotomy (POEM): mid-term efficacy and safety. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. NEW YORK: SPRINGER, 2018, roč. 32, č. 3, s. 1293-1302. ISSN 0930-2794. Dostupné z: https://dx.doi.org/10.1007/s00464-017-5807-3.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Per-oral endoscopic myotomy (POEM): mid-term efficacy and safety
Autoři MARTINEK, Jan (203 Česká republika, garant), Hana SVECOVA (203 Česká republika), Zuzana VACKOVA (203 Česká republika), Radek DOLEZEL (203 Česká republika), Ondřej NGO (203 Česká republika, domácí), Jana KRAJCIOVA (203 Česká republika), Eva KIESLICHOVA (203 Česká republika), Radek JANOUSEK (203 Česká republika), Alexander PAZDRO (203 Česká republika), Tomas HARUSTIAK (203 Česká republika), Lucie ZDRHOVA (203 Česká republika), Pavla LOUDOVA (203 Česká republika), Petr STIRAND (203 Česká republika) a Julius SPICAK (203 Česká republika).
Vydání SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, NEW YORK, SPRINGER, 2018, 0930-2794.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30212 Surgery
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.209
Kód RIV RIV/00216224:14110/18:00102802
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1007/s00464-017-5807-3
UT WoS 000424654800027
Klíčová slova anglicky Per-oral endoscopic myotomy; Achalasia; Gastroesophageal reflux
Štítky 14119612, EL OK, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 10. 2. 2019 17:20.
Anotace
Background and aims Per-oral endoscopic myotomy (POEM) is becoming a standard treatment for achalasia. Long-term efficacy and the rate of post-POEM reflux should be further investigated. The main aim of this study was to analyze safety and mid-term (12 and 24 months) clinical outcomes of POEM. Methods Data on single tertiary center procedures were collected prospectively. The primary outcome was treatment success defined as an Eckardt score <3 at 12 and 24 months. A total of 155 consecutive patients with achalasia underwent POEM; 133 patients were included into the analysis (22 patients will be analyzed separately as part of a multicenter randomized clinical trial). Results POEM was successfully completed in 132 (99.2%) patients, and the mean length of the procedure was 69.8 min (range 31-136). One patient underwent a drainage for pleural effusion; no other serious adverse events occurred. Treatment success at 3, 12, and 24 months was observed in 95.5% (CI 89.6-98.1), 93.4% (86.5-96.8), and 84.0% (71.4-91.4) of patients, respectively. A total of 11 patients (8.3%) reported initial treatment failure (n = 5) or later recurrence (n = 6). The majority of relapses occurred in patients with achalasia type I (16.7 vs. 1.1% achalasia type II vs. 0% achalasia type III; p < 0.05). At 12 months, post-POEM reflux symptoms were present in 29.7% of patients. At 3 months, mild reflux esophagitis was diagnosed in 37.6% of patients, and pathological gastroesophageal reflux was detected in 41.5% of patients. A total of 37.8% of patients had been treated with a proton pump inhibitor. Conclusion POEM resulted in greater than 90% treatment success at 12 months which tends to decrease to 84% after 2 years. More than one-third of the patients had mild reflux symptoms and/or mild esophagitis.
VytisknoutZobrazeno: 24. 4. 2024 18:54